Skip to content
Search

Latest Stories

Well buys Norfolk-based pharmacy chain Pharma-Z

Well Pharmacy, the UK’s largest independent pharmacy chain, has added six new pharmacies to its portfolio of 750 after acquiring Pharma-Z, a small pharmacy chain based in Norfolk.

In a statement on Monday (March 1) Well said all 46 employees of the six community pharmacy sites will be retained as part of the acquisition to continue offering important healthcare services and customer care to patients in the local community.


“We are delighted to further support the health and wellbeing of new patients and communities in the Norfolk area," said Seb Hobbs, CEO of Well Pharmacy.

"At Well our mission is to build the best community pharmacy experience in the UK, and we believe this acquisition will help us get one step closer to achieving that. We are thrilled to welcome nearly 50 new colleagues to the Well family.

“Despite the ongoing funding challenges facing pharmacy, Well continues to invest in the sector showing our commitment to pharmacy and offering accessible healthcare services to local communities.

“Our Delivering Well strategy sets out our long-term growth ambitions, and the pandemic has further highlighted the essential service and care we offer local communities by providing vital healthcare, advice, medication, NHS and private services to almost 2 million patients every month.”

Well will be rebranding the six pharmacies in due course and will prioritise onboarding its new employees into the business by proactively supporting them during the transition.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less